AHR · NYSE · STOCK
American Healthcare REIT (AHR) Stock Analysis
$53.04
52W $41.38 – $58.70
51/100
$10.86B
77.2
0.80
Is AHR Bullish or Bearish?
Mixed.
Innellis AI committee rates American Healthcare REIT (AHR) Watch with a composite score of 51/100
, based on 6 analysts with 33% agreement.
Last updated October 14, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +9.47 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -10.53 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — current ratio of 0.70 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 95.3 is expensive by classic value standards — Value
- ROE of only 3.7% -- cheap may mean cheap for a reason — Value
- 3 consecutive earnings misses -- execution concerns — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- Current ratio of 0.70 is tight -- limited short-term liquidity cushion — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 14, 2026
Overall Committee Score
51/100
Agreement
33%
Analysts
6
Conviction
Contested
Sector Rank
Top 81%
of 80 Real Estate peers
Value Analyst
neutral
44
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 95.3 is expensive by classic value standards
Growth Analyst
bearish
40
/ 100 · High confidence
Growth story is weak, decelerating, or inconsistent
− 3 consecutive earnings misses -- execution concerns
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Current ratio of 0.70 is tight -- limited short-term liquidity cushion
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
61
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
bearish
35
/ 100 · Low confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− 2 existing position pair(s) are highly correlated already
Investment Thesis Evolution
Committee score moved marginally from 53.2 to 50.5.
- Bullish support removed: 1 signal(s) disappeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Macro Analyst: score 80->65 (-15).
- Portfolio Manager: score 30->35 (+5).
Comparing 2026-10-13 to 2026-10-14 (1 day apart).
Technical Analysis
RSI (14)
61.7
Neutral
MACD Histogram
0.283
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$52.34
Resistance
$54.48
Bollinger %B
0.72
Inside Bands
Price vs Moving Averages
EMA 9
$51.60
Above
EMA 21
$51.92
Above
EMA 50
$52.77
Above
EMA 200
$50.48
Above
Fundamental Analysis
Valuation
60
Growth
43
Profitability
12
Financial Health
50
Cash Flow
70
Valuation
P/E Ratio
77.2×
P/B Ratio
2.70×
PEG Ratio
0.07
Dividend Yield
1.90%
52W High
$58.70
52W Low
$41.38
Quality & Growth
ROE
210.2%
ROA
128.7%
Gross Margin
1493.9%
Operating Margin
674.1%
Revenue Growth YoY
—
Debt / Equity
0.42
AI Fundamental Assessment
P/E ratio of 77.2 (rich relative to a 15-40x range); Price-to-book of 2.7x; PEG ratio of 0.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 2.1%; Return on assets of 1.3%; Net margin of 4.8%; Gross margin of 14.9%; Current ratio of 0.18 (tight short-term liquidity); Debt-to-equity of 0.42; Free cash flow per share is positive (1.38); Most recent quarter missed estimates by 4.0%; 3 consecutive earnings misses; EPS growth decelerating (+116.7% -> +23.1% QoQ); Average YoY EPS growth of 14.3%; Analyst estimates rising over recent quarters
Get the Full AHR Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →